细胞淋巴瘤-话题@MedSci

#细胞淋巴瘤#

385篇内容 | 5356人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1702534, encodeId=967f1e02534c0, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=NEJM：Tisagenlecleucel用于复发或难治性弥漫性大B细胞淋巴瘤, objectType=article, longId=155103, objectId=ddf415510378, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ddf415510378, replyNumber=0, likeNumber=51, createdTime=2019-07-31, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ddf415510378, moduleTitle=NEJM：Tisagenlecleucel用于复发或难治性弥漫性大B细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ddf415510378)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702503, encodeId=23831e02503e4, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Blood：来那度胺联合obinutuzumab用于复发性/难治性滤泡性B细胞淋巴瘤的安全性和疗效, objectType=article, longId=145755, objectId=8b22145e5508, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b22145e5508, replyNumber=0, likeNumber=65, createdTime=2018-10-09, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b22145e5508, moduleTitle=Blood：来那度胺联合obinutuzumab用于复发性/难治性滤泡性B细胞淋巴瘤的安全性和疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b22145e5508)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702509, encodeId=8bf11e0250982, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=JCO：循环肿瘤DNA作为弥漫大B细胞淋巴瘤早期结局预测指标, objectType=article, longId=147188, objectId=34ac14e18870, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34ac14e18870, replyNumber=0, likeNumber=91, createdTime=2018-12-01, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34ac14e18870, moduleTitle=JCO：循环肿瘤DNA作为弥漫大B细胞淋巴瘤早期结局预测指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=34ac14e18870)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702476, encodeId=27981e02476ff, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=P53基因重排/突变的白血病非淋巴结套细胞淋巴瘤对利妥昔单抗/伊布替尼组合疗法高度敏感, objectType=article, longId=133937, objectId=40e013393ec7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40e013393ec7, replyNumber=0, likeNumber=69, createdTime=2018-08-06, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40e013393ec7, moduleTitle=P53基因重排/突变的白血病非淋巴结套细胞淋巴瘤对利妥昔单抗/伊布替尼组合疗法高度敏感, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=40e013393ec7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702515, encodeId=cf5d1e0251585, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Blood：来那度胺联合利妥昔单抗作为套细胞淋巴瘤的初始治疗，缓解率高且持久, objectType=article, longId=148333, objectId=c82614833341, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c82614833341, replyNumber=0, likeNumber=63, createdTime=2019-06-12, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c82614833341, moduleTitle=Blood：来那度胺联合利妥昔单抗作为套细胞淋巴瘤的初始治疗，缓解率高且持久, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c82614833341)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702536, encodeId=6c841e02536c3, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Lancet oncol：依鲁替尼联合奥比托珠单抗治疗慢性淋巴细胞白血病或小淋巴细胞淋巴瘤的效果和安全性, objectType=article, longId=155391, objectId=a3ed15539185, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3ed15539185, replyNumber=0, likeNumber=64, createdTime=2018-12-22, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3ed15539185, moduleTitle=Lancet oncol：依鲁替尼联合奥比托珠单抗治疗慢性淋巴细胞白血病或小淋巴细胞淋巴瘤的效果和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3ed15539185)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702530, encodeId=19d81e025307f, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=2018 BSH指南：原发性中枢神经系统弥漫性大B细胞淋巴瘤的诊断和管理, objectType=article, longId=154562, objectId=e874154562ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e874154562ec, replyNumber=0, likeNumber=14, createdTime=2018-12-29, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e874154562ec, moduleTitle=2018 BSH指南：原发性中枢神经系统弥漫性大B细胞淋巴瘤的诊断和管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e874154562ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702507, encodeId=54f81e0250753, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=柳叶刀公布了Kyowa Kirin公司CCR4单抗Poteligeo 治疗皮肤T细胞淋巴瘤的III期临床数据, objectType=article, longId=146735, objectId=31ee146e35d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31ee146e35d9, replyNumber=0, likeNumber=79, createdTime=2019-05-23, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31ee146e35d9, moduleTitle=柳叶刀公布了Kyowa Kirin公司CCR4单抗Poteligeo 治疗皮肤T细胞淋巴瘤的III期临床数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=31ee146e35d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702545, encodeId=e5731e025458c, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=NCCN临床实践指南：T细胞淋巴瘤（2019.V2）, objectType=article, longId=157213, objectId=0d0915e213b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0d0915e213b0, replyNumber=0, likeNumber=13, createdTime=2019-05-11, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d0915e213b0, moduleTitle=NCCN临床实践指南：T细胞淋巴瘤（2019.V2）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0d0915e213b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702522, encodeId=dec51e02522e7, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=NCCN临床实践指南：B细胞淋巴瘤（2018.V5）, objectType=article, longId=151309, objectId=621815130954, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=621815130954, replyNumber=0, likeNumber=12, createdTime=2019-04-27, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=621815130954, moduleTitle=NCCN临床实践指南：B细胞淋巴瘤（2018.V5）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=621815130954)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702500, encodeId=a6cc1e02500e6, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=西安杨森旗下亿珂®获批适应症扩展用于一线治疗慢性淋巴细胞白血病/小淋巴细胞淋巴瘤, objectType=article, longId=144842, objectId=fd5514484242, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd5514484242, replyNumber=0, likeNumber=75, createdTime=2018-09-15, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd5514484242, moduleTitle=西安杨森旗下亿珂®获批适应症扩展用于一线治疗慢性淋巴细胞白血病/小淋巴细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd5514484242)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702474, encodeId=768d1e0247403, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Blood：弥漫性大B细胞淋巴瘤通过激活存活信号通路或获得影响药物与靶点结合的EZH2突变，从而对EZH2抑制剂耐药, objectType=article, longId=133365, objectId=e4531333650d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e4531333650d, replyNumber=0, likeNumber=76, createdTime=2018-12-29, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e4531333650d, moduleTitle=Blood：弥漫性大B细胞淋巴瘤通过激活存活信号通路或获得影响药物与靶点结合的EZH2突变，从而对EZH2抑制剂耐药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e4531333650d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702464, encodeId=eef41e02464bb, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Blood：P4HA2通过羟基化Carbin促进B细胞淋巴瘤进展, objectType=article, longId=128882, objectId=ad02128882e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad02128882e3, replyNumber=0, likeNumber=65, createdTime=2019-01-16, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad02128882e3, moduleTitle=Blood：P4HA2通过羟基化Carbin促进B细胞淋巴瘤进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad02128882e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702478, encodeId=70211e024780b, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Blood：鼻型结外NK/T细胞淋巴瘤的治疗进展, objectType=article, longId=134102, objectId=500b13410298, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=500b13410298, replyNumber=0, likeNumber=77, createdTime=2018-09-24, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=500b13410298, moduleTitle=Blood：鼻型结外NK/T细胞淋巴瘤的治疗进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=500b13410298)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702538, encodeId=33181e0253882, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=J Hematol Oncol：套细胞淋巴瘤自体造血干细胞移植后硼替佐米+利妥昔单抗疗效喜人, objectType=article, longId=155661, objectId=4497155661dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4497155661dc, replyNumber=0, likeNumber=109, createdTime=2019-05-07, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4497155661dc, moduleTitle=J Hematol Oncol：套细胞淋巴瘤自体造血干细胞移植后硼替佐米+利妥昔单抗疗效喜人, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4497155661dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702499, encodeId=76681e0249963, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Brit J Haematol：原发性纵隔B细胞淋巴瘤前线管理，R-CHOP vs DA-R-EPOCH, objectType=article, longId=144543, objectId=35051445433e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35051445433e, replyNumber=0, likeNumber=85, createdTime=2018-07-23, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35051445433e, moduleTitle=Brit J Haematol：原发性纵隔B细胞淋巴瘤前线管理，R-CHOP vs DA-R-EPOCH, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35051445433e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702482, encodeId=08001e02482a6, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=NEJM：里程碑式研究：弥漫性大B细胞淋巴瘤分类迈出更精准一步, objectType=article, longId=135549, objectId=cdbc1355495e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cdbc1355495e, replyNumber=0, likeNumber=70, createdTime=2019-03-16, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cdbc1355495e, moduleTitle=NEJM：里程碑式研究：弥漫性大B细胞淋巴瘤分类迈出更精准一步, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cdbc1355495e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702467, encodeId=0b521e024678a, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Blood：原发性纵膈大B细胞淋巴瘤的体细胞IL4R突变，激活JAK-STAT信号通路, objectType=article, longId=130399, objectId=be3a13039929, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be3a13039929, replyNumber=0, likeNumber=64, createdTime=2018-12-16, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be3a13039929, moduleTitle=Blood：原发性纵膈大B细胞淋巴瘤的体细胞IL4R突变，激活JAK-STAT信号通路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be3a13039929)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702521, encodeId=58d41e0252166, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2019.V2）, objectType=article, longId=150979, objectId=fd051509e9f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd051509e9f0, replyNumber=0, likeNumber=15, createdTime=2019-07-07, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd051509e9f0, moduleTitle=NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2019.V2）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd051509e9f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702511, encodeId=87db1e02511d4, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=百济神州宣布中国药监局接受zanubrutinib用于治疗复发/难治性套细胞淋巴瘤的新药申请, objectType=article, longId=147531, objectId=c60e14e531c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c60e14e531c9, replyNumber=0, likeNumber=73, createdTime=2018-10-23, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c60e14e531c9, moduleTitle=百济神州宣布中国药监局接受zanubrutinib用于治疗复发/难治性套细胞淋巴瘤的新药申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c60e14e531c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

细胞淋巴瘤

2020-05-29

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

NEJM：Tisagenlecleucel用于复发或难治性弥漫性大B细胞淋巴瘤

2019-07-31

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Blood：来那度胺联合obinutuzumab用于复发性/难治性滤泡性B细胞淋巴瘤的安全性和疗效

2018-10-09

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

JCO：循环肿瘤DNA作为弥漫大B细胞淋巴瘤早期结局预测指标

2018-12-01

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

P53基因重排/突变的白血病非淋巴结套细胞淋巴瘤对利妥昔单抗/伊布替尼组合疗法高度敏感

2018-08-06

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Blood：来那度胺联合利妥昔单抗作为套细胞淋巴瘤的初始治疗，缓解率高且持久

2019-06-12

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Lancet oncol：依鲁替尼联合奥比托珠单抗治疗慢性淋巴细胞白血病或小淋巴细胞淋巴瘤的效果和安全性

2018-12-22

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

2018 BSH指南：原发性中枢神经系统弥漫性大B细胞淋巴瘤的诊断和管理

2018-12-29

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

柳叶刀公布了Kyowa Kirin公司CCR4单抗Poteligeo 治疗皮肤T细胞淋巴瘤的III期临床数据

2019-05-23

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

NCCN临床实践指南：T细胞淋巴瘤（2019.V2）

2019-05-11

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

NCCN临床实践指南：B细胞淋巴瘤（2018.V5）

2019-04-27

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

西安杨森旗下亿珂®获批适应症扩展用于一线治疗慢性淋巴细胞白血病/小淋巴细胞淋巴瘤

2018-09-15

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Blood：弥漫性大B细胞淋巴瘤通过激活存活信号通路或获得影响药物与靶点结合的EZH2突变，从而对EZH2抑制剂耐药

2018-12-29

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Blood：P4HA2通过羟基化Carbin促进B细胞淋巴瘤进展

2019-01-16

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Blood：鼻型结外NK/T细胞淋巴瘤的治疗进展

2018-09-24

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

J Hematol Oncol：套细胞淋巴瘤自体造血干细胞移植后硼替佐米+利妥昔单抗疗效喜人

2019-05-07

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Brit J Haematol：原发性纵隔B细胞淋巴瘤前线管理，R-CHOP vs DA-R-EPOCH

2018-07-23

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

NEJM：里程碑式研究：弥漫性大B细胞淋巴瘤分类迈出更精准一步

2019-03-16

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Blood：原发性纵膈大B细胞淋巴瘤的体细胞IL4R突变，激活JAK-STAT信号通路

2018-12-16

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2019.V2）

2019-07-07

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

百济神州宣布中国药监局接受zanubrutinib用于治疗复发/难治性套细胞淋巴瘤的新药申请

2018-10-23

科室
- - 订阅+
  - 更多科室
工具
服务